Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein

Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory illness and has a high mortality of ∼34%. However, since its discovery in 2012, an effective vaccine has not been developed for it. To develop a vaccine against multiple strains of MERS-CoV, we targeted spike glycoprot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Main Authors: Choi, Jung-ah, Goo, Junghyun, Yang, Eunji, Jung, Dae-Im, Lee, Sena, Rho, Semi, Jeong, Yuji, Park, Young-Shin, Park, Hayan, Moon, Young-hye, Park, Uni, Seo, Sang-Hwan, Lee, Hyeja, Lee, Jae Myun, Cho, Nam-Hyuk, Song, Manki, Kim, Jae-Ouk
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2020
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7925194/
https://ncbi.nlm.nih.gov/pubmed/32967955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01176-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados